Kang-Mieler JJ - Search Results

1

Controlled and Extended In Vitro Release of Bioactive Anti-Vascular Endothelial Growth Factors from a Microsphere-Hydrogel Drug Delivery System.

Osswald CR, Kang-Mieler JJ. Osswald CR, et al. Curr Eye Res. 2016 Sep;41(9):1216-22. doi: 10.3109/02713683.2015.1101140. Epub 2016 Jan 14. Curr Eye Res. 2016. PMID: 26764892

2

Objective area measurement technique for choroidal neovascularization from fluorescein angiography.

Guthrie MJ, Osswald CR, Valio NL, Mieler WF, Kang-Mieler JJ. Guthrie MJ, et al. Microvasc Res. 2014 Jan;91:1-7. doi: 10.1016/j.mvr.2013.11.005. Epub 2013 Dec 5. Microvasc Res. 2014. PMID: 24316422 Free PMC article.

3

Advances in ocular drug delivery: emphasis on the posterior segment.

Kang-Mieler JJ, Osswald CR, Mieler WF. Kang-Mieler JJ, et al. Expert Opin Drug Deliv. 2014 Oct;11(10):1647-60. doi: 10.1517/17425247.2014.935338. Epub 2014 Jun 30. Expert Opin Drug Deliv. 2014. PMID: 24975820 Review.

4

Inverse relationship between the intraretinal concentration of bioavailable nitric oxide and blood glucose in early experimental diabetic retinopathy.

Guthrie MJ, Osswald CR, Kang-Mieler JJ. Guthrie MJ, et al. Invest Ophthalmol Vis Sci. 2014 Dec 11;56(1):37-44. doi: 10.1167/iovs.14-15777. Invest Ophthalmol Vis Sci. 2014. PMID: 25503458

5

Controlled and Extended Release of a Model Protein from a Microsphere-Hydrogel Drug Delivery System.

Osswald CR, Kang-Mieler JJ. Osswald CR, et al. Ann Biomed Eng. 2015 Nov;43(11):2609-17. doi: 10.1007/s10439-015-1314-7. Epub 2015 Apr 3. Ann Biomed Eng. 2015. PMID: 25835212

6

Extended ocular drug delivery systems for the anterior and posterior segments: biomaterial options and applications.

Kang-Mieler JJ, Dosmar E, Liu W, Mieler WF. Kang-Mieler JJ, et al. Expert Opin Drug Deliv. 2017 May;14(5):611-620. doi: 10.1080/17425247.2016.1227785. Epub 2016 Sep 1. Expert Opin Drug Deliv. 2017. PMID: 27551742 Review.

7

In Vivo Efficacy of an Injectable Microsphere-Hydrogel Ocular Drug Delivery System.

Osswald CR, Guthrie MJ, Avila A, Valio JA Jr, Mieler WF, Kang-Mieler JJ. Osswald CR, et al. Curr Eye Res. 2017 Sep;42(9):1293-1301. doi: 10.1080/02713683.2017.1302590. Epub 2017 May 30. Curr Eye Res. 2017. PMID: 28557571

8

Biodegradable Microsphere-Hydrogel Ocular Drug Delivery System for Controlled and Extended Release of Bioactive Aflibercept In Vitro.

Liu W, Lee BS, Mieler WF, Kang-Mieler JJ. Liu W, et al. Curr Eye Res. 2019 Mar;44(3):264-274. doi: 10.1080/02713683.2018.1533983. Epub 2018 Oct 19. Curr Eye Res. 2019. PMID: 30295090 Free PMC article.

9

Characterization of Biodegradable Microsphere-Hydrogel Ocular Drug Delivery System for Controlled and Extended Release of Ranibizumab.

Liu W, Borrell MA, Venerus DC, Mieler WF, Kang-Mieler JJ. Liu W, et al. Transl Vis Sci Technol. 2019 Jan 22;8(1):12. doi: 10.1167/tvst.8.1.12. eCollection 2019 Jan. Transl Vis Sci Technol. 2019. PMID: 30701127 Free PMC article.

10

Controlled Release of Vancomycin From a Thermoresponsive Hydrogel System for the Prophylactic Treatment of Postoperative Acute Endophthalmitis.

Dosmar E, Liu W, Patel G, Rogozinski A, Mieler WF, Kang-Mieler JJ. Dosmar E, et al. Transl Vis Sci Technol. 2019 Jun 27;8(3):53. doi: 10.1167/tvst.8.3.53. eCollection 2019 May. Transl Vis Sci Technol. 2019. PMID: 31293808 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters